| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Characterization and Outcomes of Spanish Patients With Relapsed/Refractory Multiple Myeloma Included in the LocoMMotion Study
|
Mateos, Maria-Victoria
|
|
|
24 |
4 |
p. 224-231.e2
|
artikel
|
| 2 |
Chimeric Antigen Receptor T - Cell Therapy for Large B-Cell Lymphoma Patients with Central Nervous System Involvement, a Systematic Review and Meta-analysis
|
Elgohary, Ghada
|
|
|
24 |
4 |
p. e142-e151
|
artikel
|
| 3 |
Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic Leukemia
|
Short, Nicholas J.
|
|
|
24 |
4 |
p. e168-e173
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
24 |
4 |
p. A6-A7
|
artikel
|
| 5 |
Effect of Tyrosine Kinase Inhibitor Therapy on Estimated Glomerular Filtration Rate in Patients with Chronic Myeloid Leukemia
|
Sönmez, Özge
|
|
|
24 |
4 |
p. 232-239
|
artikel
|
| 6 |
Epidemiologic Characteristics, Treatment Patterns, and Survival Analysis of Plasmablastic Lymphoma in the United States: A SEER and NCDB Analysis
|
Hansen, Alec R.
|
|
|
24 |
4 |
p. e152-e160.e3
|
artikel
|
| 7 |
Folinic Acid Over: Rescue of Intermediate Dose Methotrexate
|
Cohen, Ian J.
|
|
|
24 |
4 |
p. 269-270
|
artikel
|
| 8 |
Immunoglobulin High Throughput Sequencing (Ig-HTS) Minimal Residual Disease (MRD) Analysis is an Effective Surveillance Tool in Patients With Mantle Cell Lymphoma
|
Rezazadeh, Alexandra
|
|
|
24 |
4 |
p. 254-259
|
artikel
|
| 9 |
Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II Trial
|
Matasar, Matthew
|
|
|
24 |
4 |
p. 240-253
|
artikel
|
| 10 |
Prognostic Impact of Bone Marrow Fibrosis and Effects of Tyrosine Kinase Inhibitors on Bone Marrow Fibrosis in Chronic Myeloid Leukemia
|
Pepeler, Mehmet Sezgin
|
|
|
24 |
4 |
p. e161-e167
|
artikel
|
| 11 |
Racial Disparities in Mycosis Fungoides/Sézary Syndrome–A Single-Center Observational Study of 292 Patients
|
Gandham, Ashley R.
|
|
|
24 |
4 |
p. e174-e180
|
artikel
|
| 12 |
Real-world Effectiveness of Azacitidine in Treatment-Naive Patients With Higher-risk Myelodysplastic Syndromes
|
Rajakumaraswamy, Nishanthan
|
|
|
24 |
4 |
p. 260-268.e2
|
artikel
|
| 13 |
Recent Advances in the Biology and CD123-Directed Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
|
Pemmaraju, Naveen
|
|
|
24 |
4 |
p. e130-e137
|
artikel
|
| 14 |
Second Treatment-Free Remission Attempt in Patients with Chronic Myeloid Leukemia
|
Ureshino, Hiroshi
|
|
|
24 |
4 |
p. e138-e141
|
artikel
|
| 15 |
SOHO State of the Art Updates and Next Questions: Chronic Myeloid Leukemia and Pregnancy: “Per Aspera Ad Astra”
|
Abruzzese, Elisabetta
|
|
|
24 |
4 |
p. 214-223
|
artikel
|
| 16 |
SOHO State of the Art Updates and Next Questions: Oral Therapy in Acute Myeloid Leukemia
|
Nasnas, Patrice
|
|
|
24 |
4 |
p. 205-213
|
artikel
|
| 17 |
Table of Contents
|
|
|
|
24 |
4 |
p. A8-A10
|
artikel
|
| 18 |
Utilization of Autologous Hematopoietic Cell Transplantation Over Time in Multiple Myeloma: A Population-Based Study
|
Esteghamat, Naseem S.
|
|
|
24 |
4 |
p. e119-e129
|
artikel
|
Tijdschrift beschrijving